Affymetrix Appoints Masao Yoneyama as General Manager of Japan Operations
Dr. Yoneyama brings 20 years of experience in the life sciences industry to Affymetrix. His specific areas of expertise are toxicogenomics, pharmacogenomics and molecular diagnostics. He joins Affymetrix from Daiichi Pure Chemicals Co., Ltd., where he was the general manager of business development. He was responsible for research and development and creating new business opportunities in several different areas, including personalized medicine, point-of-care testing, food safety and toxicology.
Dr. Yoneyama holds a bachelor's degree in chemistry, Master of Science degree and a doctorate in toxicology from Utah State University. He also holds a diploma from Ikutoku Technical College (Japan) in chemical engineering.
Most read news
Topics
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.